Bullish case
$145 to $160
More likely if Japan sales stay strong, U.S. premiums keep growing, yen pressure fades, forward adjusted EPS stabilizes or improves, buybacks reduce share count, and the market pays about 15x forward earnings.
Aflac Incorporated research snapshot
AFL AI stock analysis currently reads Aflac Incorporated as a high-quality supplemental insurance franchise with strong Japan and U.S. positions, conservative underwriting culture, steady capital returns, yen sensitivity, and a valuation that already prices in stability. At the August 2, 2026 data cutoff, AFL closed near $127.48 on July 31, 2026 with an independently verified market capitalization of about $64.89 billion, above the analyst consensus target of $117.71. This page uses scenarios, technical levels, and source-backed facts. It is informational research, not investment advice.
Current price
$127.48
Market cap
$64.89 billion
AI score
70 / 100
Rating
Quality insurer, valuation now full
Trend status
Uptrend above key moving averages, testing the 52-week high
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Aflac sells supplemental health and life insurance mainly through Aflac Japan and Aflac U.S., with cash generation supported by persistency, scale, and investment income. | High |
| Moat | The moat comes from trusted brand recognition, distribution reach, Japan market leadership in cancer and medical insurance, regulatory know-how, and decades of policyholder relationships. | Medium-high |
| Management | Daniel P. Amos has led the company for decades. The key test is whether management can keep capital returns disciplined while adapting Japan and U.S. sales channels and building the reinsurance franchise. | Medium-high |
| Financial trend | TTM revenue recovered to about $18.11 billion with TTM net income near $4.64 billion and EPS of $8.81, but FY2025 earnings declined and forward adjusted EPS estimates point to a decline in 2026. | High |
| Valuation | At $127.48, AFL traded near 14.5x TTM GAAP EPS and about 18x forward adjusted EPS, 2.17x book value, and a 1.9% dividend yield, above the analyst consensus price target. | High |
| Technical trend | The daily setup is constructive with price above the 50-day and 200-day moving averages and a 14-day RSI of 64.99, but the stock is testing resistance near the $130.22 52-week high. | Medium |
| Risk level | Main risks are currency translation, the expected decline in forward adjusted EPS, Japanese premium pressure, lower persistency, reserve changes, investment losses, and slow U.S. growth. | Medium-high |
| AI confidence | High for descriptive research and calculations. Lower for exact price outcomes because insurer earnings can move with rates, currency, claims, and accounting marks. | High data confidence |
| Investment certainty | Medium certainty. AFL looks like a resilient business, but a buy decision depends on price, currency view, forward EPS trajectory, and confidence in the capital return program. | Medium |
AFL AI stock forecast
The AFL AI stock forecast uses scenario math around the $127.48 quote, $8.81 TTM EPS, and forward adjusted EPS estimates near $7.02. The audited three-year framework produced a bearish area near $78, a base area near $122, and a bullish area near $153 before dividends, with the caveat that the stock already trades above the analyst consensus target.
$145 to $160
More likely if Japan sales stay strong, U.S. premiums keep growing, yen pressure fades, forward adjusted EPS stabilizes or improves, buybacks reduce share count, and the market pays about 15x forward earnings.
$112 to $128
More likely if adjusted EPS holds near analyst estimates, persistency remains steady, book value grows modestly, and investors value AFL around a 13x earnings multiple, consistent with the analyst consensus target near $117.71.
$75 to $90
More likely if yen weakness, reserve changes, claims pressure, investment losses, or a faster decline in forward adjusted EPS reduce earnings and compress the multiple toward 10x.
AFL AI technical analysis
AFL AI technical analysis is constructive as of the August 2, 2026 cutoff. StockAnalysis reported a 14-day RSI of 64.99, a 50-day moving average of $119.64, a 200-day moving average of $113.33, and a closing price of $127.48 on July 31, 2026.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $127.48 | StockAnalysis close on July 31, 2026, used for market cap and valuation math at the August 2, 2026 cutoff. |
| Near support | $119.60 to $121.00 | The 50-day moving average near $119.64 and the recent trading area create the first support zone to watch. |
| Near resistance | $128.00 to $130.22 | The July 31 intraday high near $128.03 and the 52-week high of $130.22 form the resistance zone ahead of the August 6, 2026 earnings report. |
| 50-day moving average | $119.64 | Price remained well above this level, supporting the intermediate trend. |
| 200-day moving average | $113.33 | Price remained above the 200-day average, keeping the long-term trend constructive. |
| Momentum | 14-day RSI 64.99 | RSI was positive but approaching overbought, so momentum supports the trend while caution is reasonable near resistance. |
| Volume | About 1.82 million average daily shares | StockAnalysis listed average daily volume near 1.82 million shares, enough liquidity for most large-cap monitoring frameworks. |
| Volatility | Moderate insurer volatility, low beta of 0.60 | Expect larger moves around earnings, yen moves, rate changes, reserve updates, and capital return announcements. |
| Invalidation | Close below $119.64, then $113.33 | A close below the 50-day average would weaken the short-term setup. A break below the 200-day average would be a more serious trend warning. |
AFL AI trading strategy
The AFL AI trading strategy is a rules-based research framework for a mature insurer with visible capital returns and currency sensitivity. It is not personal advice and should be paired with live quotes, filings, position sizing, and risk controls.
Watch for AFL to hold above the 50-day moving average and clear the $128.00 to $130.22 resistance area with volume confirmation, especially around the August 6, 2026 earnings report.
A close below $119.64 or a failed breakout after earnings should invalidate the short-term setup.
If AFL pulls back toward the 200-day moving average without a new underwriting, reserve, or currency shock, compare the price reaction with book value, ROE, and buyback activity.
Do not average down without a defined loss limit because insurance stocks can reprice quickly when accounting marks or claim trends change.
Track Japan sales, U.S. net earned premiums, persistency, adjusted EPS, adjusted ROE, book value per share, yen translation, adjusted leverage near 21%, ESR near 227%, buybacks, and dividend growth.
Reduce confidence if forward adjusted EPS keeps falling or returns rely mainly on valuation expansion rather than underwriting profit, investment income, book-value growth, and lower share count.
Investment research summary
Aflac converts trusted distribution, supplemental insurance products, policy persistency, and invested float into recurring premiums, investment income, and shareholder returns.
The moat is strongest in brand, Japan market presence, regulatory experience, distribution, and long policyholder relationships. It narrows if new channels, pricing pressure, or better digital competitors reduce acquisition strength.
The thesis fails if Japan premiums decline faster than expected, yen weakness persists, claims or reserves deteriorate, investment marks damage book value, forward adjusted EPS falls, or buybacks occur at poor prices.
Daniel Amos gives Aflac rare leadership continuity. The risk is key-person dependence and the need to modernize sales channels and grow the reinsurance business without weakening the conservative culture that built the franchise.
Supplemental insurance benefits from healthcare cost gaps, aging populations, and consumer need for cash benefits, but growth is mature and Japan underlying earned premium is still declining, so the industry is not a high-growth category.
AFL is not priced as a troubled insurer. At $127.48 it sits above the analyst consensus target of $117.71, so margin of safety depends on steady ROE, disciplined buybacks, dividend durability, and whether investors accept about 18x forward adjusted earnings.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| AFL price | $127.48 close on July 31, 2026 | StockAnalysis quote snapshot | August 1, 2026 |
| Market capitalization | $64.89 billion, verified as $127.48 x 508.98 million shares | financial_rigor.py market cap verification | August 1, 2026 |
| FY2025 revenue | $17.164 billion, down 9.31% | Aflac 2025 Form 10-K, StockAnalysis, and Macrotrends cross-check | August 1, 2026 |
| FY2025 net earnings | $3.646 billion, down 33.01% | Aflac 2025 Form 10-K and StockAnalysis cross-check | August 1, 2026 |
| TTM financials | Revenue $18.11 billion, net income $4.64 billion, EPS $8.81 | StockAnalysis income statement (TTM ending March 2026) | August 1, 2026 |
| Q1 2026 adjusted EPS | $1.75, up 6.6% year over year excluding foreign currency | Aflac Q1 2026 earnings call transcript (April 30, 2026) | August 1, 2026 |
| Q1 2026 Japan sales | Up 25.5% year over year, with US persistency of 79.3% | Aflac Q1 2026 earnings call transcript | August 1, 2026 |
| Cash and debt | $8.27 billion cash and $14.46 billion total debt | StockAnalysis statistics and Yahoo Finance cross-check | August 1, 2026 |
| Book value per share | $58.69 at March 31, 2026 | StockAnalysis statistics and Aflac Q1 2026 release | August 1, 2026 |
| Capital position | Adjusted leverage 21.2%, estimated ESR 227%, $1.3 billion returned in Q1 | Aflac Q1 2026 earnings call transcript | August 1, 2026 |
| Analyst consensus | Hold rating, average target $117.71, range $98 to $137 | StockAnalysis analyst forecast (S&P Global) | July 22, 2026 |
| Technical snapshot | RSI 64.99, 50-day MA $119.64, 200-day MA $113.33, 52-week range $96.95 to $130.22 | StockAnalysis statistics | August 1, 2026 |
This AFL AI stock analysis is an informational research tool only. It is not investment advice, a recommendation, or a guarantee of future returns. Forecast scenarios are based on available public data as of August 2, 2026 and may be wrong if Aflac fundamentals, interest rates, currency, claims, regulation, or market valuation change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.